Amgen and MediLink to collaborate on SCLC combination therapy
Amgen and MediLink Therapeutics have agreed to a research and supply collaboration to develop a combination therapy for extensive-stage small…
Amgen and MediLink Therapeutics have agreed to a research and supply collaboration to develop a combination therapy for extensive-stage small…
Bristol Myers Squibb (BMS) has agreed to a research and licensing deal with Prime Medicine to develop ex vivo T…
At the upcoming 12th Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics meeting, experts from the pharmaceutical, biotechnology…
New data from the TROPION-Lung01 trial show datopotamab deruxtecan treatment led to greater overall survival (OS) than docetaxel chemotherapy in…
“Change begins now,” said the UK’s new prime minister, Sir Keir Starmer, in his 5 July victory speech. Ending the…
Whilst Prime Minister Rishi Sunak and Labour party leader Keir Starmer, centre attention on migration and tax policies, the UK…
As a 4 July UK general election looms on the horizon, experts say that the UK clinical trial landscape could…
Altimmune has taken another step to claim its share in the growing obesity drug market with new data showing its…
The Asia Pacific (APAC) region is leading the charge for adoptive cell therapy studies, says Scotty Chung-Siu, a managing analyst…
Dr. Yooni Kim, the vice president of clinical services at Novotech, says Australia and South Korea are emerging as bubbling…